Cargando…

What If…? Pandemic policy-decision-support to guide a cost-benefit-optimised, country-specific response

BACKGROUND: After 18 months of responding to the COVID-19 pandemic, there is still no agreement on the optimal combination of mitigation strategies. The efficacy and collateral damage of pandemic policies are dependent on constantly evolving viral epidemiology as well as the volatile distribution of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mannarini, Giorgio, Posa, Francesco, Bossy, Thierry, Massemin, Lucas, Fernandez-Castanon, Javier, Chavdarova, Tatjana, Cañas, Pablo, Gupta, Prakhar, Jaggi, Martin, Hartley, Mary-Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022143/ https://www.ncbi.nlm.nih.gov/pubmed/36962770 http://dx.doi.org/10.1371/journal.pgph.0000721

Ejemplares similares

Optimising the benefits from research institutes
por: Lagrange, Thierry
Publicado: (2020)

DeepBreath—automated detection of respiratory pathology from lung auscultation in 572 pediatric outpatients across 5 countries
por: Heitmann, Julien, et al.
Publicado: (2023)

The Wheat Aleurone Layer: Optimisation of Its Benefits and Application to Bakery Products
por: Lebert, Lucie, et al.
Publicado: (2022)

Haptic communication optimises joint decisions and affords implicit confidence sharing
por: Pezzulo, Giovanni, et al.
Publicado: (2021)

Rational Risk-Benefit Decision-Making in the Setting of Military Mefloquine Policy
por: Nevin, Remington L.
Publicado: (2015)

Potential negative impact of reputed regulators’ decisions on the approval status of new cancer drugs in Latin American countries: A descriptive analysis
por: Durán, Carlos E., et al.
Publicado: (2021)

Policy parameters for optimising hospital ePrescribing: An exploratory literature review of selected countries of the Organisation for Economic Co-operation and Development
por: Perera, Uditha T, et al.
Publicado: (2022)

THE ROLE OF POLICY CONTEXT IN INDIVIDUAL LONG-TERM CARE DECISIONS IN OECD COUNTRIES
por: Caldera, Selena
Publicado: (2019)

Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
por: Evans, Marc, et al.
Publicado: (2019)

Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries
por: Massad, Eduardo, et al.
Publicado: (2011)

Multiple micronutrient supplementation cost–benefit tool for informing maternal nutrition policy and investment decisions
por: Verney, Allison M. J., et al.
Publicado: (2023)

Optimisation solutions in systems
por: Rubio, Fernando, et al.
Publicado: (2018)

Embedding health policy and systems research into decision-making processes in low- and middle-income countries
por: Koon, Adam D, et al.
Publicado: (2013)

Improved hepatitis C screening and treatment in people who inject drugs should be a priority in Europe
por: Kautz, Achim, et al.
Publicado: (2014)

Health Status of Afghan Refugees in Europe: Policy and Practice Implications for an Optimised Healthcare
por: Matsangos, Michael, et al.
Publicado: (2022)

Modular Clinical Decision Support Networks (MoDN)—Updatable, interpretable, and portable predictions for evolving clinical environments
por: Trottet, Cécile, et al.
Publicado: (2023)

Advanced multiresponse process optimisation: an intelligent and integrated approach
por: Šibalija, Tatjana V, et al.
Publicado: (2016)

Mood fluctuations shift cost–benefit tradeoffs in economic decisions
por: Heerema, Roeland, et al.
Publicado: (2023)

Improving transportation networks: Effects of population structure and decision making policies
por: Pablo-Martí, Federico, et al.
Publicado: (2017)

The costs and benefits of cannabis control policies 
por: Hall, Wayne
Publicado: (2020)

Cost and benefit of military quarantine policies
por: Hall, Andrew, et al.
Publicado: (2021)

Increased knowledge of Francisella genus diversity highlights the benefits of optimised DNA-based assays
por: Ahlinder, Jon, et al.
Publicado: (2012)

Patient perspectives on how to optimise benefits from a breathlessness service for people with COPD
por: Luckett, Tim, et al.
Publicado: (2020)

Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
por: Louis, Edouard, et al.
Publicado: (2022)

EE20 An Overview of Optimisation Studies on COVID-19 and Its Economic Benefits in India
por: Harika, E, et al.
Publicado: (2022)

Optimising remanufacturing decision-making using the bees algorithm in product digital twins
por: Kerin, Mairi, et al.
Publicado: (2023)

Optimising Nutrition and Hydration in Care Homes—Getting It Right in Person Rather than in Policy
por: Donaldson, Alison I. C., et al.
Publicado: (2018)

European Central Bank׳s monetary policy decisions: A dataset of two decades of press conferences
por: Warin, Thierry, et al.
Publicado: (2018)

Energy policies of IEA countries /
Publicado: (1991)

Energy policies of IEA countries.
Publicado: (1997)

Population policy in developed countries /
Publicado: (1974)

The Milk Supply of the Country: Policy?
por: Simpson, J. C.
Publicado: (1931)

Developed-developing country partnerships: Benefits to developed countries?
por: Syed, Shamsuzzoha B, et al.
Publicado: (2012)

Perspectives of policy and political decision makers on access to formal dementia care: expert interviews in eight European countries
por: Broda, Anja, et al.
Publicado: (2017)

Cervical screening during the COVID-19 pandemic: optimising recovery strategies
por: Castanon, Alejandra, et al.
Publicado: (2021)

How do decision-makers use evidence in community health policy and financing decisions? A qualitative study and conceptual framework in four African countries
por: Kumar, Meghan Bruce, et al.
Publicado: (2020)

Optimising breast cancer screening reading: blinding the second reader to the first reader’s decisions
por: Cooper, Jennifer A., et al.
Publicado: (2021)

Optimising Decision Making in Chronic Venous Disease Management with Micronised Purified Flavonoid Fraction
por: Ulloa, Jorge H.
Publicado: (2023)

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand’s pharmaceutical benefit package
por: Anothaisintawee, Thunyarat, et al.
Publicado: (2012)

Health benefits of policies to reduce carbon emissions
por: Milner, James, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2tmqho1638je7j4edahgtvrrlt